- Home
- ED vs GEHC Comparison
ED vs GEHC Comparison
Compare ED & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ED
- GEHC
- Stock Information
- Founded
- ED 1884
- GEHC 1892
- Country
- ED United States
- GEHC United States
- Employees
- ED N/A
- GEHC N/A
- Industry
- ED Power Generation
- GEHC Computer Software: Prepackaged Software
- Sector
- ED Utilities
- GEHC Technology
- Exchange
- ED Nasdaq
- GEHC Nasdaq
- Market Cap
- ED 34.8B
- GEHC 37.5B
- IPO Year
- ED N/A
- GEHC N/A
- Fundamental
- Price
- ED $90.05
- GEHC $78.91
- Analyst Decision
- ED Hold
- GEHC Buy
- Analyst Count
- ED 14
- GEHC 13
- Target Price
- ED $97.73
- GEHC $95.46
- AVG Volume (30 Days)
- ED 2.5M
- GEHC 3.3M
- Earning Date
- ED 02-13-2025
- GEHC 02-13-2025
- Dividend Yield
- ED 3.69%
- GEHC 0.18%
- EPS Growth
- ED N/A
- GEHC 8.27
- EPS
- ED 5.31
- GEHC 3.65
- Revenue
- ED $15,031,000,000.00
- GEHC $19,559,000,000.00
- Revenue This Year
- ED $7.24
- GEHC $2.72
- Revenue Next Year
- ED $3.87
- GEHC $4.08
- P/E Ratio
- ED $16.94
- GEHC $21.62
- Revenue Growth
- ED N/A
- GEHC 1.43
- 52 Week Low
- ED $85.85
- GEHC $71.31
- 52 Week High
- ED $107.75
- GEHC $94.55
- Technical
- Relative Strength Index (RSI)
- ED 28.08
- GEHC 36.91
- Support Level
- ED $88.37
- GEHC $80.47
- Resistance Level
- ED $97.32
- GEHC $81.78
- Average True Range (ATR)
- ED 1.64
- GEHC 1.56
- MACD
- ED -0.51
- GEHC -0.26
- Stochastic Oscillator
- ED 15.21
- GEHC 31.35
About ED Consolidated Edison Inc.
Con Ed is a holding company for Consolidated Edison of New York, or CECONY, and Orange & Rockland, or O&R. These utilities provide steam, natural gas, and electricity to customers in southeastern New York—including New York City—and small parts of New Jersey. The two utilities generate nearly all of Con Ed's earnings following the sale of its clean energy business to RWE in early 2023.
About GEHC GE HealthCare Technologies Inc.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (54% of revenue), ultrasound (18%), patient care solutions (16%), and pharmaceutical diagnostics (12%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 44%, 26%, 14%, and 16% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (33% of revenue), pharmaceutical diagnostics (12%), and digital solutions (6%).